M3-Brigade Acquisition V Corp. Warrant (NASDAQ: MBAVW) represents a detachable warrant issued by M3-Brigade Acquisition V Corp., a special purpose acquisition company (SPAC) formed to identify and complete a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination. The warrants were issued as part of units in the company’s initial public offering in November 2021 and began trading separately on the NASDAQ Global Market under the ticker MBAVW.
Each warrant entitles the holder to purchase one Class A ordinary share of M3-Brigade Acquisition V Corp. at an exercise price of $11.50 per share, subject to customary anti-dilution and adjustment provisions in the warrant agreement. The warrants become exercisable upon the closing of the company’s initial business combination and expire five years from the date of the IPO, unless redeemed, exercised or otherwise cancelled earlier. Under specified conditions—such as the share price exceeding the exercise price for a defined period—the company may call warrants for cash redemption.
M3-Brigade Acquisition V Corp. is sponsored jointly by M3, Inc., a Tokyo-based digital healthcare and medical information services provider, and Brigade Capital Management, a global credit investment firm headquartered in New York. The combined management teams bring extensive experience in healthcare markets, financial services and corporate development. The SPAC structure offers investors exposure to a future target business while the warrants provide additional leverage and potential upside upon successful completion of a qualifying transaction.
The company is incorporated in Delaware and governed by U.S. federal securities laws and NASDAQ rules. Investors considering MBAVW should review the company’s registration statement, prospectus and warrant agreement for detailed information on exercise mechanics, redemption rights, expiration, transfer restrictions and other material terms. These documents outline the SPAC’s timeline for completing a business combination and the rights and obligations of warrant holders under various corporate scenarios.
AI Generated. May Contain Errors.